<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39434011</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>Comparison of genotypic features between two groups of antibiotic resistant Klebsiella pneumoniae clinical isolates obtained before and after the COVID-19 pandemic from Egypt.</ArticleTitle><Pagination><StartPage>983</StartPage><MedlinePgn>983</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">983</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-024-10661-z</ELocationID><Abstract><AbstractText>Klebsiella pneumoniae is a common pathogen capable of causing a wide range of infections. Antibiotic resistance complicates treatment of these infections significantly. We are comparing resistance levels and genotypes among two collections of K. pneumoniae clinical isolates from Alexandria Main University Hospital (AMUH). We used disc diffusion and Minimum Inhibitory Concentration (MIC) by microbroth dilution to assess resistance levels and performed whole genome sequencing (WGS) to describe multilocus sequence types (MLST) and resistance gene presence. Among a collection of 56 K. pneumoniae clinical isolates (19 from 2019 to 37 from 2021), multidrug resistance (MDR) was 33% and 10%, extended drug resistance (XDR) was 24% and 46% and pan-drug resistance (PDR) was 43% and 43%, respectively. We identified 15 MLST STs including two novel types (ST-6118 and ST-6119 ). ST-101 and ST-383 were common between the two collections; ST-101 was the most common genotype in 2019 (28.6%) and ST-147 was most common in 2021 (25%). Ampicillin/sulbactam, amikacin, cefepime, ceftriaxone and ertapenem MICs were significantly higher in 2021. Prevalence of aph(3') - Ia, aph(3')-VI, mphA was significantly higher in 2021. The increasing resistance levels and the persistence of some MDR/XDR genotypes is concerning. Understanding mechanisms of resistance will inform infection control and antimicrobial stewardship plans to prevent evolution and spread of XDR and PDR strains.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gamaleldin</LastName><ForeName>Pansee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Alexandria Main University Hospital, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alseqely</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, 1 Khartoum Sq, Alexandria, 21521, Egypt. mustafa.alseqely@alexu.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Norwich Medical School, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Hoda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, 1 Khartoum Sq, Alexandria, 21521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abouelfetouh</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, 1 Khartoum Sq, Alexandria, 21521, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Alamein International University, New Alamein, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007711" MajorTopicYN="Y">Klebsiella pneumoniae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="Y">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007710" MajorTopicYN="N">Klebsiella Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024901" MajorTopicYN="N">Drug Resistance, Multiple, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058885" MajorTopicYN="N">Multilocus Sequence Typing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carbapenem resistance</Keyword><Keyword MajorTopicYN="N">ESBLs</Keyword><Keyword MajorTopicYN="N">Multi-locus sequence typing (MLST)</Keyword><Keyword MajorTopicYN="N">Multidrug resistance (MDR)</Keyword><Keyword MajorTopicYN="N">Whole-genome sequencing (WGS)</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434011</ArticleId><ArticleId IdType="pmc">PMC11492754</ArticleId><ArticleId IdType="doi">10.1186/s12864-024-10661-z</ArticleId><ArticleId IdType="pii">10.1186/s12864-024-10661-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482–501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6604941</ArticleId><ArticleId IdType="pubmed">31294229</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins RR, Bonomo RA. Overview: global and local impact of antibiotic resistance. Infect Disease Clin. 2016;30(2):313–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">27208761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman SB, et al. A review on antibiotic resistance: alarm bells are ringing. Cureus. 2017;9(6):e1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573035</ArticleId><ArticleId IdType="pubmed">28852600</ArticleId></ArticleIdList></Reference><Reference><Citation>Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88898</ArticleId><ArticleId IdType="pubmed">9767057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung PY. The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation. FEMS Microbiol Lett, 2016. 363(20).</Citation><ArticleIdList><ArticleId IdType="pubmed">27664057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, et al. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Review of Anti-infective Therapy; 2018. p. 16.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester CH. Fuursted K. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis. 2010;10(12):829–30. Walsh TR.</Citation><ArticleIdList><ArticleId IdType="pubmed">21109169</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibl A, Memish Z, Khader SA. Al-Agamy M, Memish Z, Senok A, Khader SA Assiri A. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 2013;17(12):e1130–3</Citation><ArticleIdList><ArticleId IdType="pubmed">24021566</ArticleId></ArticleIdList></Reference><Reference><Citation>Livermore DM. Multiresistant gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):736–55. Turton JF.</Citation><ArticleIdList><ArticleId IdType="pubmed">21303394</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Uria G, et al. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis. 2018;68:50–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889426</ArticleId><ArticleId IdType="pubmed">29410253</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab R et al. Antimicrobial Resistance and Comparative Genome Analysis of Klebsiella pneumoniae strains isolated in Egypt. Microorganisms, 2021. 9(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465295</ArticleId><ArticleId IdType="pubmed">34576775</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Domany RA, et al. Analysis of the correlation between antibiotic resistance patterns and virulence determinants in pathogenic Klebsiella pneumoniae isolates from Egypt. Microb Drug Resist. 2021;27(6):727–39.</Citation><ArticleIdList><ArticleId IdType="pubmed">33103956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif M, et al. Whole-genome sequencing of Egyptian multidrug-resistant Klebsiella pneumoniae isolates: a multi-center pilot study. Eur J Clin Microbiol Infect Dis. 2021;40(7):1451–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">33559021</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic laboratory procedures in clinical bacteriology / J. Vandepitte … et al.]. 1991, World Health Organization: Geneva.</Citation></Reference><Reference><Citation>AMR NG. .H.R.U.o.G.S.o., whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap. BMJ Glob Health, 2020. 5(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689591</ArticleId><ArticleId IdType="pubmed">33239336</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard DH. The preservation of bacteria by freezing in glycerol broth. J Bacteriol. 1956;71(5):625–625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC357863</ArticleId><ArticleId IdType="pubmed">13331878</ArticleId></ArticleIdList></Reference><Reference><Citation>CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601225</ArticleId><ArticleId IdType="pubmed">34550809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan AA, et al. Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli. Sci Rep. 2019;9(1):4224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6414621</ArticleId><ArticleId IdType="pubmed">30862858</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankevich A, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342519</ArticleId><ArticleId IdType="pubmed">22506599</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JJ, et al. The PATRIC Bioinformatics Resource Center: expanding data and analysis capabilities. Nucleic Acids Res. 2020;48(D1):D606–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145515</ArticleId><ArticleId IdType="pubmed">31667520</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks DH, et al. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015;25(7):1043–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4484387</ArticleId><ArticleId IdType="pubmed">25977477</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyam A, et al. Sequenceserver: a modern graphical user interface for Custom BLAST databases. Mol Biol Evol. 2019;36(12):2922–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6878946</ArticleId><ArticleId IdType="pubmed">31411700</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho C, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10(1):421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2803857</ArticleId><ArticleId IdType="pubmed">20003500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolaia V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75(12):3491–500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662176</ArticleId><ArticleId IdType="pubmed">32780112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatusova T, et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016;44(14):6614–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001611</ArticleId><ArticleId IdType="pubmed">27342282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt M, et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb Genom. 2017;3(10):e000131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5695208</ArticleId><ArticleId IdType="pubmed">29177089</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Nickle DC, Liu Y, Kosakovsky Pond SL. Maust BS, Nickle DC, Learn GH, Liu Y, Heath L, Kosakovsky Pond SL, Mullins JI. DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. BioTechniques 2010;48(5):405–8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3133969</ArticleId><ArticleId IdType="pubmed">20569214</ArticleId></ArticleIdList></Reference><Reference><Citation>Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186(5):1518–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC344416</ArticleId><ArticleId IdType="pubmed">14973027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaas RS, et al. Solving the Problem of comparing whole bacterial genomes across different sequencing platforms. PLoS ONE. 2014;9(8):e104984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4128722</ArticleId><ArticleId IdType="pubmed">25110940</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, et al. The differences and similarities between two-sample T-Test and paired T-Test. Shanghai Arch Psychiatry. 2017;29(3):184–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5579465</ArticleId><ArticleId IdType="pubmed">28904516</ArticleId></ArticleIdList></Reference><Reference><Citation>Abril D, et al. Within patient genetic diversity of blaKPC harboring Klebsiella pneumoniae in a Colombian hospital and identification of a new NTEKPC platform. Sci Rep. 2021;11(1):21409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8560879</ArticleId><ArticleId IdType="pubmed">34725422</ArticleId></ArticleIdList></Reference><Reference><Citation>Maseda E, et al. Bugs, hosts and ICU environment: countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting. Rev Esp Anestesiol Reanim. 2014;61(3):e1–19.</Citation><ArticleIdList><ArticleId IdType="pubmed">24492197</ArticleId></ArticleIdList></Reference><Reference><Citation>Effah CY, et al. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7050612</ArticleId><ArticleId IdType="pubmed">31918737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi W, et al. Extensively drug-resistant Klebsiella pneumoniae causing nosocomial bloodstream infections in China: Molecular Investigation of Antibiotic Resistance determinants, informing therapy, and clinical outcomes. Front Microbiol. 2017;8:1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5492486</ArticleId><ArticleId IdType="pubmed">28713357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shebl E, et al. The outcome of hospital-acquired pneumonia in patients admitted for long-term care according to the antibiotic duration. Egypt J Chest Disease Tuberculosis. 2019;68:378–82.</Citation></Reference><Reference><Citation>Hassuna NA, et al. Extensively-drug resistant Klebsiella pneumoniae recovered from neonatal Sepsis cases from a major NICU in Egypt. Front Microbiol. 2020;11:1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317144</ArticleId><ArticleId IdType="pubmed">32636828</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Baz AA, et al. Prevalence and Antibiotic Resistance profiles of Carbapenem-Resistant Klebsiella Pneumoniae isolated from Tertiary Care Hospital, Egypt. Egypt J Hosp Med. 2022;88(1):2883–90.</Citation></Reference><Reference><Citation>Sharma A, et al. Changing Trend in the Antibiotic Resistance Pattern of Klebsiella Pneumonia isolated from endotracheal aspirate samples of ICU patients of a Tertiary Care Hospital in North India. Cureus. 2023;15(3):e36317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10106535</ArticleId><ArticleId IdType="pubmed">37077586</ArticleId></ArticleIdList></Reference><Reference><Citation>Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022 eClinicalMedicine, 2023. 57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9900305</ArticleId><ArticleId IdType="pubmed">36776504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulman ZP, et al. Genomic Features Associated with the degree of phenotypic resistance to Carbapenems in Carbapenem-resistant Klebsiella pneumoniae. mSystems. 2021;6(5):e0019421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547452</ArticleId><ArticleId IdType="pubmed">34519526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska-Krochmal B, Dudek-Wicher R. The Minimum Inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens, 2021. 10(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7913839</ArticleId><ArticleId IdType="pubmed">33557078</ArticleId></ArticleIdList></Reference><Reference><Citation>Carattoli A. An ertapenem-resistant extended-spectrum-betalactamase- producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother. 2010;54(10):4178–84. Mancini C.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2944588</ArticleId><ArticleId IdType="pubmed">20660683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri C et al. The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases Antibiotics (Basel), 2021. 10(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388901</ArticleId><ArticleId IdType="pubmed">34439062</ArticleId></ArticleIdList></Reference><Reference><Citation>De Koster S, et al. Diversity in the characteristics of Klebsiella pneumoniae ST101 of Human, Environmental, and animal origin. Front Microbiol. 2022;13:838207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8866942</ArticleId><ArticleId IdType="pubmed">35222344</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, et al. Nosocomial outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese hospital: Clonal Transmission of ST147 and ST383. PLoS ONE. 2016;11(8):e0160754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973971</ArticleId><ArticleId IdType="pubmed">27490695</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman EA et al. Klebsiella pneumonia in Sudan: Multidrug Resistance, polyclonal dissemination, and virulence. Antibiot (Basel), 2023. 12(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952582</ArticleId><ArticleId IdType="pubmed">36830144</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe CC et al. Diversity, virulence, and Antimicrobial Resistance in isolates from the newly emerging Klebsiella pneumoniae ST101 lineage. Front Microbiol, 2019. 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454207</ArticleId><ArticleId IdType="pubmed">31001209</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M et al. Genomic evolution and local epidemiology of Klebsiella pneumoniae from a major hospital in Beijing, China, over a 15 year period: dissemination of known and novel high-risk clones. Microb Genom, 2019. 7(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8627660</ArticleId><ArticleId IdType="pubmed">33629946</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, et al. Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea. Ann Clin Microbiol Antimicrob. 2023;22(1):76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10464262</ArticleId><ArticleId IdType="pubmed">37620875</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo JQ, et al. Genomic surveillance of Carbapenem-resistant Klebsiella pneumoniae from a Major Public Health Hospital in Singapore. Microbiol Spectr. 2022;10(5):e0095722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9602435</ArticleId><ArticleId IdType="pubmed">36066252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>